ReviewDrugs2011

Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions.

H Benjamin Starnes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.